期刊文献+

华蟾素胶囊治疗癌性疼痛的临床疗效观察 被引量:26

Observation on the Clinical Therapeutic Effect of Cinobufacin Capsules in the Treatment of Cancer Pain
暂未订购
导出
摘要 目的:探讨华蟾素胶囊对癌性疼痛的临床疗效。方法:将我院治疗的63例恶性肿瘤患者随机分为治疗组33例和西药组30例,西药组采用口服硫酸吗啡,治疗组口服华蟾素胶囊,对比两组治疗癌性疼痛的效果、不良反应发生率、起效时间、生活质量以及KPS和NRS评分。结果:治疗组的总有效率为93.9%,西药组为86.7%,两组无统计学差异(P>0.05);治疗组平均起效时间为(11.4±4.7)min,西药组为(29.6±5.61)min,两组相比,具有统计学差异(P<0.05);治疗后两组体重相比,治疗组体重增加率为87.9%,高于西药组60.0%(P<0.05)。两组KPS评分和NRS评分相比,无统计学差异(P>0.05)。结论:华蟾素对癌性疼痛效果明显,起效快,不良反应低。 Objective:To explore the clinical efficacy of cinobufacini Capsule on cancer pain.Methods: Select 63 cases of patients with malignant tumor in our hospital, were randomly divided into treatment group 33 cases and western medicine group of 30 cases,western medicine group were treated with oral administration of morphine sulfate, treatment group was treated with cinobufacini capsule.Comparing the two groups in the treatment of cancer pain effect, adverse reaction incidence, onset time, quality of life as well as the KPS and NRS score.Results:The total effective rate in treatment group was 93.9%, control group 86.7%, two groups had no significant difference (P〉0.05).The average onset time of treatment group was (11.4±4.7) min, the western medicine group (29.6±5.61) min, compared to the two groups, with statistical difference (P〈0.05).The two groups after treatment compared weight gain weight, the treatment group was 87.9%, higher than the western medicine group of 60%(P〈0.05).Compared two groups of KPS and NRS scores, there are no significant difference (P〉0.05).Conclusion:Effect of cinobufacini on cancer pain effect, fast acting, less adverse reactions.
作者 杨新波
出处 《中国医药导刊》 2014年第3期478-479,481,共3页 Chinese Journal of Medicinal Guide
关键词 华蟾素 癌性疼痛 疗效观察 Cinobufacini Cancer pain Clinical effect
  • 相关文献

参考文献9

二级参考文献41

  • 1韩克起,顾伟,苏永华,黄雪强,王喜,凌昌全.蟾毒灵抗小鼠原位移植性肝癌整体药效学研究[J].中华实验外科杂志,2004,21(12):1436-1438. 被引量:12
  • 2刘长安,姜恩海,贾廷珍.对我国放射性疾病诊断标准现状的讨论[J].中国卫生监督杂志,2006,13(1):36-40. 被引量:4
  • 3夏益华.辐射防护基本点的演变[J].辐射防护,2006,26(2):113-121. 被引量:5
  • 4王斌,宋燕.骨桥蛋白在结肠癌组织中的表达及血清水平检测[J].吉林大学学报(医学版),2007,33(2):324-326. 被引量:4
  • 5NURIA P,FELIPE C.Bufalin influences the repair of X-ray-induced DNA breaks in Chinese hamster cells[J].DNA Repair,2003,2(12):1353-1360.
  • 6WEIDEMANN H.Na+/K+-ATPase,endogenous digitalis like compounds and cancer development-a hypothesis[J].Front Biosci,2005,1(10):2165-2176.
  • 7ENOMOTO A,RHO MC,KOMIYAMA K,et al.Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells[J].J Nat prod,2004,67(12):2071-2072.
  • 8PRINCE CW,OOSAWA T,BUTLER WT,et al.Isolation,characterization,and biosynthesis of a phosphorylated glycoprotein from rat bone[J].J Biol Chem,1987,262(6):2900-2905.
  • 9YOU J,REILLY GC,ZHEN X,et al.Osteopontin gene regulation by oseiallatory fluid flow via intracellular caleiummobilizaion and activation of mitogenactivated protein kinase in MC3T3 El osteoblasts[J].J Biol Chem,2001,276(16):133-145.
  • 10HIRAMA M,TAKAHASHI F,TAKAHASHI K,et al.Osteopontin over-produced by tumor cells acts as a potent angiogenic factor contributing to tumor growth[J].Cancer Lett,2003,198 (1):107-117.

共引文献36

同被引文献244

引证文献26

二级引证文献210

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部